Brefel C - Search Results

1

Blockade of cholecystokinin-A receptors has no effect on dyskinesias in Parkinson's disease.

Arnulf I, Vidailhet M, Bonnet AM, Descombes S, Jaillon C, Agid Y, Brefel C, Rascol O, Xie J, Pollak P, Cattelin F. Arnulf I, et al. Among authors: brefel c. J Neurol Neurosurg Psychiatry. 2001 Jun;70(6):812-3. doi: 10.1136/jnnp.70.6.812. J Neurol Neurosurg Psychiatry. 2001. PMID: 11430293 Free PMC article. Clinical Trial. No abstract available.

2

Prevalence of orthostatic hypotension in Parkinson's disease.

Senard JM, Raï S, Lapeyre-Mestre M, Brefel C, Rascol O, Rascol A, Montastruc JL. Senard JM, et al. Among authors: brefel c. J Neurol Neurosurg Psychiatry. 1997 Nov;63(5):584-9. doi: 10.1136/jnnp.63.5.584. J Neurol Neurosurg Psychiatry. 1997. PMID: 9408097 Free PMC article.

3

A placebo-controlled study of ropinirole, a new D2 agonist, in the treatment of motor fluctuations of L-DOPA-treated parkinsonian patients.

Rascol O, Lees AJ, Senard JM, Pirtosek Z, Brefel C, Montastruc JL, Fuell D. Rascol O, et al. Among authors: brefel c. Adv Neurol. 1996;69:531-4. Adv Neurol. 1996. PMID: 8615176 Clinical Trial. No abstract available.

4

Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia.

Rascol O, Sabatini U, Brefel C, Fabre N, Rai S, Senard JM, Celsis P, Viallard G, Montastruc JL, Chollet F. Rascol O, et al. Among authors: brefel c. Brain. 1998 Mar;121 ( Pt 3):527-33. doi: 10.1093/brain/121.3.527. Brain. 1998. PMID: 9549528

5

Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease.

Albanese A, Bonuccelli U, Brefel C, Chaudhuri KR, Colosimo C, Eichhorn T, Melamed E, Pollak P, Van Laar T, Zappia M. Albanese A, et al. Among authors: brefel c. Mov Disord. 2001 Mar;16(2):197-201. doi: 10.1002/mds.1069. Mov Disord. 2001. PMID: 11295770

6

The ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic parkinsonian patients.

Rascol O, Sabatini U, Fabre N, Brefel C, Loubinoux I, Celsis P, Senard JM, Montastruc JL, Chollet F. Rascol O, et al. Among authors: brefel c. Brain. 1997 Jan;120 ( Pt 1):103-10. doi: 10.1093/brain/120.1.103. Brain. 1997. PMID: 9055801

7

Effect of the alpha 2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey.

Bezard E, Brefel C, Tison F, Peyro-Saint-Paul H, Ladure P, Rascol O, Gross CE. Bezard E, et al. Among authors: brefel c. Prog Neuropsychopharmacol Biol Psychiatry. 1999 Oct;23(7):1237-46. doi: 10.1016/s0278-5846(99)00067-6. Prog Neuropsychopharmacol Biol Psychiatry. 1999. PMID: 10581645

8

Antivertigo medications and drug-induced vertigo. A pharmacological review.

Rascol O, Hain TC, Brefel C, Benazet M, Clanet M, Montastruc JL. Rascol O, et al. Among authors: brefel c. Drugs. 1995 Nov;50(5):777-91. doi: 10.2165/00003495-199550050-00002. Drugs. 1995. PMID: 8586026 Review.

9

Effect of food on the pharmacokinetics of ropinirole in parkinsonian patients.

Brefel C, Thalamas C, Rayet S, Lopez-Gil A, Fitzpatrick K, Bullman S, Citerone DR, Taylor AC, Montastruc JL, Rascol O. Brefel C, et al. Br J Clin Pharmacol. 1998 Apr;45(4):412-5. doi: 10.1046/j.1365-2125.1998.t01-1-00704.x. Br J Clin Pharmacol. 1998. PMID: 9578193 Free PMC article. Clinical Trial.

10

Normal frontal perfusion in patients with frozen gait.

Fabre N, Brefel C, Sabatini U, Celsis P, Montastruc JL, Chollet F, Rascol O. Fabre N, et al. Among authors: brefel c. Mov Disord. 1998 Jul;13(4):677-83. doi: 10.1002/mds.870130412. Mov Disord. 1998. PMID: 9686774

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters